3B Blackbio Dx Resultados de beneficios anteriores
Pasado controles de criterios 4/6
3B Blackbio Dx's earnings have been declining at an average annual rate of -1.5%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 0.9% per year. 3B Blackbio Dx's return on equity is 16.1%, and it has net margins of 39.5%.
Información clave
-1.5%
Tasa de crecimiento de los beneficios
-3.9%
Tasa de crecimiento del BPA
Crecimiento de la industria Chemicals | 17.7% |
Tasa de crecimiento de los ingresos | -0.9% |
Rentabilidad financiera | 16.1% |
Margen neto | 39.5% |
Próxima actualización de resultados | 13 Nov 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero 3B Blackbio Dx. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 925 | 366 | 67 | 0 |
31 Mar 24 | 741 | 321 | 71 | 0 |
31 Dec 23 | 787 | 317 | 68 | 0 |
30 Sep 23 | 760 | 281 | 66 | 0 |
30 Jun 23 | 734 | 249 | 55 | 0 |
31 Mar 23 | 691 | 259 | 50 | 0 |
31 Dec 22 | 701 | 263 | 45 | 0 |
30 Sep 22 | 684 | 253 | 41 | 0 |
30 Jun 22 | 663 | 191 | 38 | 0 |
31 Mar 22 | 875 | 322 | 38 | 0 |
31 Dec 21 | 873 | 443 | 36 | 0 |
30 Sep 21 | 1,157 | 580 | 34 | 0 |
30 Jun 21 | 2,109 | 891 | 41 | 0 |
31 Mar 21 | 2,296 | 1,139 | 47 | 0 |
31 Dec 20 | 2,173 | 965 | 42 | 0 |
30 Sep 20 | 1,799 | 786 | 43 | 0 |
30 Jun 20 | 778 | 294 | 36 | 0 |
31 Mar 20 | 305 | 77 | 29 | 0 |
31 Dec 19 | 288 | 62 | 29 | 0 |
30 Sep 19 | 274 | 62 | 27 | 0 |
30 Jun 19 | 255 | 54 | 26 | 0 |
31 Mar 19 | 240 | 52 | 26 | 0 |
31 Dec 18 | 234 | 45 | 24 | 0 |
30 Sep 18 | 235 | 38 | 23 | 0 |
30 Jun 18 | 234 | 35 | 22 | 0 |
31 Mar 18 | 235 | 34 | 21 | 0 |
31 Dec 17 | 212 | 29 | 22 | 0 |
30 Sep 17 | 197 | 24 | 21 | 0 |
30 Jun 17 | 180 | 18 | 21 | 0 |
31 Mar 17 | 164 | 11 | 20 | 0 |
31 Dec 16 | 178 | 9 | 20 | 0 |
30 Sep 16 | 178 | 9 | 20 | 0 |
30 Jun 16 | 173 | 5 | 20 | 0 |
31 Mar 16 | 174 | 3 | 20 | 0 |
31 Dec 15 | 193 | 2 | 33 | 2 |
30 Sep 15 | 180 | 3 | 33 | 2 |
30 Jun 15 | 189 | 3 | 20 | 0 |
31 Mar 15 | 190 | 2 | 19 | 0 |
31 Dec 14 | 160 | 1 | 39 | 2 |
30 Sep 14 | 181 | 0 | 37 | 2 |
30 Jun 14 | 207 | 0 | 20 | 0 |
31 Mar 14 | 220 | 4 | 34 | 2 |
31 Dec 13 | 212 | 3 | 32 | 2 |
Ingresos de calidad: 532067 has high quality earnings.
Margen de beneficios creciente: 532067's current net profit margins (39.5%) are higher than last year (34%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 532067's earnings have declined by 1.5% per year over the past 5 years.
Acelerando crecimiento: 532067's earnings growth over the past year (46.8%) exceeds its 5-year average (-1.5% per year).
Beneficios vs. Industria: 532067 earnings growth over the past year (46.8%) exceeded the Chemicals industry 10.4%.
Rentabilidad financiera
Alta ROE: 532067's Return on Equity (16.1%) is considered low.